Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


14.01.2019

1 Alzheimer Dis Assoc Disord
1 Alzheimers Dement
1 BMC Neurol
1 Exp Neurol
1 J Alzheimers Dis
1 J Am Geriatr Soc
1 J Neurol Neurosurg Psychiatry
1 J Neurosci
2 Lancet
2 Nat Med
1 Nat Rev Neurol
1 Neurobiol Aging
1 Neurobiol Dis
2 Neurology
1 Neurosci Lett
3 PLoS One
1 Science


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimer Dis Assoc Disord

  1. HAN JY, Besser LM, Xiong C, Kukull WA, et al
    Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia.
    Alzheimer Dis Assoc Disord. 2019 Jan 9. doi: 10.1097/WAD.0000000000000291.
    PubMed     Text format     Abstract available


    Alzheimers Dement

  2. THOMAS KR, Eppig JS, Weigand AJ, Edmonds EC, et al
    Artificially low mild cognitive impairment to normal reversion rate in Alzheimer's Disease Neuroimaging Initiative.
    Alzheimers Dement. 2019 Jan 2. pii: S1552-5260(18)33603.
    PubMed     Text format     Abstract available


    BMC Neurol

  3. SANDELIUS A, Cullen NC, Kallen A, Rosengren L, et al
    Transient increase in CSF GAP-43 concentration after ischemic stroke.
    BMC Neurol. 2018;18:202.
    PubMed     Text format     Abstract available


    Exp Neurol

  4. HESSE R, von Einem B, Wagner F, Bott P, et al
    sAPPbeta and sAPPalpha increase structural complexity and E/I input ratio in primary hippocampal neurons and alter Ca(2+) homeostasis and CREB1-signaling.
    Exp Neurol. 2018;304:1-13.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  5. KHOONSARI PE, Shevchenko G, Herman S, Remnestal J, et al
    Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers.
    J Alzheimers Dis. 2019 Jan 3. pii: JAD180855. doi: 10.3233/JAD-180855.
    PubMed     Text format     Abstract available


    J Am Geriatr Soc

  6. ROYALL DR
    Comment on Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without Dementia.
    J Am Geriatr Soc. 2019 Jan 11. doi: 10.1111/jgs.15752.
    PubMed     Text format    


    J Neurol Neurosurg Psychiatry

  7. SHEN XN, Niu LD, Wang YJ, Cao XP, et al
    Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies.
    J Neurol Neurosurg Psychiatry. 2019 Jan 10. pii: jnnp-2018-319148.
    PubMed     Text format     Abstract available


    J Neurosci

  8. MELO HM
    Potential Effects of Aspirin on Lysosomal Biogenesis and Amyloid-beta Clearance: An Old Drug and Novel Insights in Alzheimer's Disease Therapy.
    J Neurosci. 2019;39:197-198.
    PubMed     Text format    


    Lancet

  9. SCHOTT JM, Aisen PS, Cummings JL, Howard RJ, et al
    Unsuccessful trials of therapies for Alzheimer's disease.
    Lancet. 2019;393:29.
    PubMed     Text format    

  10. ANDERSON RM, Hadjichrysanthou C, Evans S, McRae-McKee K, et al
    Unsuccessful trials of therapies for Alzheimer's disease - Authors' reply.
    Lancet. 2019;393:29-30.
    PubMed     Text format    


    Nat Med

  11. CHEN X, Gan L
    An exercise-induced messenger boosts memory in Alzheimer's disease.
    Nat Med. 2019;25:20-21.
    PubMed     Text format    

  12. LOURENCO MV, Frozza RL, de Freitas GB, Zhang H, et al
    Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's models.
    Nat Med. 2019;25:165-175.
    PubMed     Text format     Abstract available


    Nat Rev Neurol

  13. PANZA F, Lozupone M, Logroscino G, Imbimbo BP, et al
    A critical appraisal of amyloid-beta-targeting therapies for Alzheimer disease.
    Nat Rev Neurol. 2019 Jan 4. pii: 10.1038/s41582-018-0116.
    PubMed     Text format     Abstract available


    Neurobiol Aging

  14. VOGLEIN J, Noachtar S, McDade E, Quaid KA, et al
    Seizures as an early symptom of autosomal dominant Alzheimer's disease.
    Neurobiol Aging. 2018;76:18-23.
    PubMed     Text format     Abstract available


    Neurobiol Dis

  15. SHARMAN MJ, Gyengesi E, Liang H, Chatterjee P, et al
    Assessment of diets containing curcumin, epigallocatechin-3-gallate, docosahexaenoic acid and alpha-lipoic acid on amyloid load and inflammation in a male transgenic mouse model of Alzheimer's disease: Are combinations more effective?
    Neurobiol Dis. 2019 Jan 2. pii: S0969-9961(18)30770.
    PubMed     Text format     Abstract available


    Neurology

  16. KANTARCI K, Jicha GA
    Development of (1)H MRS biomarkers for tracking early predementia Alzheimer disease.
    Neurology. 2019 Jan 4. pii: WNL.0000000000006839.
    PubMed     Text format    

  17. OSSENKOPPELE R, Smith R, Ohlsson T, Strandberg O, et al
    Associations between tau, Abeta, and cortical thickness with cognition in Alzheimer disease.
    Neurology. 2019 Jan 9. pii: WNL.0000000000006875.
    PubMed     Text format     Abstract available


    Neurosci Lett

  18. CHIBA Y, Fujishiro H, Iseki E, Kasanuki K, et al
    Retraction notice to "The cingulate island sign in patients with dementia with Lewy bodies or Alzheimer's disease: A direct comparison between 18F-FDG PET and 123I-IMP SPECT"NSL Volume 683, 14 September 2018, Pages 168-173.
    Neurosci Lett. 2019;690:237.
    PubMed     Text format    


    PLoS One

  19. HUYNH MB, Ouidja MO, Chantepie S, Carpentier G, et al
    Glycosaminoglycans from Alzheimer's disease hippocampus have altered capacities to bind and regulate growth factors activities and to bind tau.
    PLoS One. 2019;14:e0209573.
    PubMed     Text format     Abstract available

  20. SATO S, Ueki M
    Fast score test with global null estimation regardless of missing genotypes.
    PLoS One. 2018;13:e0199692.
    PubMed     Text format     Abstract available

  21. EVANS S, Clarke D, Dowell NG, Tabet N, et al
    Using event-related fMRI to examine sustained attention processes and effects of APOE epsilon4 in young adults.
    PLoS One. 2018;13:e0198312.
    PubMed     Text format     Abstract available


    Science

  22. KORTE M
    Neuronal function of Alzheimer's protein.
    Science. 2019;363:123-124.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: